GlobeNewswire
BioRestorative Announces Pricing of $5.0 Million Public Offering
➖
AI Sentiment
Neutral
4/10
BioRestorative Therapies Inc. (NV) News
Latest updates and market news for BRTX
3 news
Feb 7 - Feb 13, 2026
Page 1
GlobeNewswire
BioRestorative Announces Positive Outcome from Type B Meeting with FDA
📈
AI Sentiment
Highly Positive
9/10
GlobeNewswire
BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease
📈
AI Sentiment
Highly Positive
9/10
Share this news page